Explore evidence

3.4 visitsThe mean visit number on which the HRP2-based RDT was still positive after treatment was 3.4 visits with a 95% confidence interval of 2.7 to 4.1.

Burkina Fasopaludismepublished 2012Tropical medicine & international health : TM & IHeurope_pmcdocument of 6 observations

80.8 %In the dry season, 80.8% and 79.8% of patients with a negative RDT were nevertheless diagnosed and treated for malaria.

Burkina Fasopaludismeobserved dry seasonpublished 2009Tropical medicine & international health : TM & IHeurope_pmcdocument of 4 observationsDOI 10.1111/j.1365-3156.2009.02246.x

97.1 %67 cases of Plasmodium falciparum malaria were diagnosed, representing 97.1% of the 69 malaria cases.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

58 %The positive predictive value for history of fever was 58% among pregnant women with suspected clinical malaria.

Burkina Fasopaludismepublished 2013Malaria journaleurope_pmcdocument of 9 observations

78.5 %In the town of Koudougou, 78.5% of city dwellers living less than 500 metres from a water body perceived their risk of malaria contamination as very high.

Burkina FasopaludismeHAL · Unilimdocument of 110 observations

46 %In Burkina Faso, a quasi-experimental study in Kaya district showed a 46% drop in febrile episodes among 2,523 children after SMC introduction.

Burkina Fasofebrile episodesHAL · Unilimdocument of 147 observations

5 %The prevalence of HIV drug resistance mutations (HIVDRM) is scored as low (≤ 5%) in all five study sites — Thailand, Vietnam, Burkina Faso, Côte d'Ivoire, and Senegal — for the three drug classes analyzed.

Burkina Faso · Côte d'Ivoire · SénégalVIH/sidapublished 2009AIDS Research and Human RetrovirusesOpenAlexdocument of 3 observations

15.4 %In Gaoua, the sporozoite infection rate (SIR) was 15.4% in year 3.

Burkina Fasopaludismeobserved year 3HAL · Unilimdocument of 87 observations

78.5 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 78.5% showed a 2-fold increase in anti-CSP IgG antibody titres post-2021 as measured by GSK ELISA.

Burkina Faso · Malipaludismeobserved post-2021HAL · Unilimdocument of 105 observations

64.38 %Mortality rates for Bendiocarb ranged from 64.38% to 98.02% in Anopheles gambiae complex populations in western Burkina Faso during the 2016 rainy season.

Burkina Fasopaludismeobserved 2016 rainy seasonpublished 2019Acta tropicaeurope_pmcdocument of 6 observations

38.6 %Of the 57 patients who were febrile on examination (axillary temperature >38.0°C), 22 had malaria, representing 38.6%.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

8.4 %La fréquence de la neuropathie sensitive, sensitivo-motrice et polyneuropathique chez les personnes vivant avec le VIH au Burkina Faso était de 8,4 % en 2008.

Burkina Fasoneuropathie périphérique · VIH/sidaobserved 2008HAL · Unilimdocument of 747 observations

1.3 %Erysipelas accounted for 1.3% of fever aetiologies among the 306 patients.

Burkina FasoerysipelasHAL · Unilimdocument of 83 observations

32.6 %Malaria prevalence among febrile adults from non-malaria endemic countries travelling or living in Burkina Faso was 32.6% for journeys over 3 months without appropriate chemoprophylaxis.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

25.7 %The prevalence of the triple Pfdhfr mutation N51I + C59R + S108N was 25.7% among 101 genotyped samples.

Burkina Fasopaludismeobserved 2010published 2017Malaria journaleurope_pmcdocument of 10 observations

3.43 odds_ratioDyslipidemia was identified as an independent risk factor for hypertension with an odds ratio of 3.43.

Burkina Fasohypertension artériellepublished 2015International journal of hypertensioneurope_pmcdocument of 7 observationsDOI 10.1155/2015/979631

52 %Headache was reported in 52% of the 200 pregnant women with suspected clinical malaria.

Burkina Fasopaludismepublished 2013Malaria journaleurope_pmcdocument of 9 observations

85.9 %At day 42, the PCR-corrected adequate clinical and parasitological response (ACPR) was 85.9% in the intention-to-treat population receiving the dispersible-tablet formulation of dihydroartemisinin/piperaquine phosphate.

Burkina Fasopaludismepublished 2018Antimicrobial agents and chemotherapyeurope_pmcdocument of 10 observations

5.5 %31 (5.5%) MOHR cases were from Burkina Faso.

Burkina Fasomaladie à virus EbolaHAL · Unilimdocument of 187 observations

459 casesBetween 2008 and 2013, 459 cases with a new diagnosis of gastro-oesophageal cancer were enrolled in the MCC-Spain study.

Burkina Fasogastro-oesophageal cancerobserved 2008-2013published 2015Gaceta sanitariaeurope_pmcdocument of 9 observations

54.4 titerAfter three vaccinations, the PfCSP-specific geometric mean titer (GMT) increased to 54.4 at day 70 in the ProC6C-AlOH/Matrix-M group.

Burkina Fasopaludismeobserved D70HAL · Unilimdocument of 39 observations

53.4 %At first antenatal visit (ANC1), parasitemia prevalence was 53.4% in the iron supplementation group and 55.3% in the control group.

Burkina Fasopaludismepublished 2018The Journal of infectious diseaseseurope_pmcdocument of 7 observations

13 %Digestive symptoms had sensitivity of 13.0% and specificity of 62.9% for malaria diagnosis.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

55 %Malaria prevalence at the first antenatal visit was 55% in the folic acid alone control group.

Burkina Fasopaludismepublished 2019Malaria journaleurope_pmcdocument of 8 observationsDOI 10.1186/s12936-019-2797-8

23 %According to Sabatinelli et al. (1986), 23% of malaria-related deaths recorded worldwide are attributable to environmental factors.

Burkina Fasopaludismeobserved 1986HAL · Unilimdocument of 110 observations